Skip to main content
FinSpry Logo
FinSpry
RMD logo
RMD
(NYSE)
ResMed Inc.
$224.09-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

ResMed (RMD) Stock Price & Financial Analysis

ResMed Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$219.01 - $226.30
52-Week High$293.81
52-Week Low$199.92
Open$220.99
Volume626.86K
Average Volume (3M)626.86K
Market Cap32.80B
Shares Outstanding146.37M
P/E Ratio (TTM)21.95
Forward P/E18.45
Price to Sales (P/S)6.04
Price to Book (P/B)5.16
EV/EBITDA15.25
Revenue (TTM)5.40B
Net Income (TTM)1.49B
Free Cash Flow (TTM)1.78B
EPS (TTM)$10.15
Profit Margin27.53%
Operating Margin34.14%
Return on Equity (ROE)23.51%
Debt to Equity0.11
50-Day MA$247.80
200-Day MA$259.09
52-Week Change0.25%
Annual Dividend$2.33
Dividend Yield1.05%
Payout Ratio22.95%
Last Dividend Ex-DateFeb 12, 2026

Frequently Asked Questions About ResMed

What is the current stock price for RMD?

As of the latest trading session, RMD stock trades at $224.09. The 52-week range is $199.92–$293.81, with a day range of $219.01–$226.30.

What is the P/E ratio for RMD?

ResMed's trailing P/E ratio is 21.9, meaning investors pay $21.9 for every $1 of annual earnings. The forward P/E is 18.4, reflecting analyst expectations for future earnings. ResMed operates in the Healthcare sector.

Does RMD pay dividends?

Yes, ResMed pays a 1.05% annual dividend yield ($2.33 per share). The payout ratio is 22.9%. The last ex-dividend date was 2026-02-12.

What do analysts recommend for RMD?

Based on 11 analysts, the consensus for RMD is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of RMD?

ResMed's market capitalization is $32.80B, classifying it as a large-cap company. ResMed operates in the Healthcare sector within the Medical Instruments & Supplies industry.